Social Media Sidebar


Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

Just because something doesn’t do what you planned it to do doesn’t mean it’s useless.


Thomas Edison

New Cancer Therapy Shows Promise in Treating Aggressive Brain Tumours

Posted in Medicine on 3rd Jan, 2017 04:27 PM by AlexMuller

By boosting the power of a patient’s immune cells, researchers from the City of Hope Beckman Research Institute have demonstrated the potential for a revolutionary new therapy to treat a particularly aggressive form of brain cancer. But given the limited results, many questions remain.

Things were starting to look bleak for a 50-year-old patient being treated for a deadly form of brain cancer known as recurrent multifocal glioblastoma, an often fatal condition in which cancer spreads to multiple parts of the brain and spinal column. The patient was not responding to the usual battery of treatments, including radiation, surgery, and anti-tumour medications, so the doctors decided to enroll him a clinical trial designed to test the safety of a new cancer treatment called CAR-T cell therapy.
Seven-and-a-half months later, the patient’s tumour had shrunk to virtually nothing, and he went into remission. Had the patient not received the experimental treatment, his doctors say he would have likely died by now. The tumours have since returned, but importantly, not in the areas of the brain that were treated. It’s a limited result, but an important precedent for an immunotherapy that had previously only been shown to work with blood cancers.
These results, now published in the New England Journal of Medicine, couldn’t have come at a better time. CAR-T immunotherapy, in which white blood cells are reprogrammed to attack cancer cells, took a hit recently following the deaths of four cancer patients enrolled in a Juno Therapeutics Phase II clinical trial. It’s not clear if the deaths were due to a reaction between a chemotherapy drug and CAR-T, or if they were caused by CAR-T alone. It’s simply too early to know, leading to criticisms that the experimental therapy is being overhyped and oversold.
These concerns notwithstanding, the early enthusiasm is understandable. In a study conducted earlier this year, 94 percent of terminally ill patients who were treated with CAR-T went into remission. This immunotherapy has shown promise in treating blood cancers like lymphomas and leukemias, and it’s become an indelible part of President Obama’s ambitious “Moonshot” to accelerate cancer research. And now, as the first results from an application of CAR-T directly to a cancer site show, this therapy may be used to combat solid tumors as well.
To get things started, a research team led by Benham Badie extracted immune cells, specifically T cells, from the patient, and then added a receptor that helps the cells target specific tumours. Unlike unmodified T cells, which attack and then die, these jacked cells stick around in a patient’s immune system for a long period of time (possibly a decade or more, the researchers say), and grow a new batch of cancer-killing cells that can attack and destroy future tumor cells.
Following surgery to remove most of the patient’s brain tumour, surgeons injected the site with the CAR-T cells. This was repeated five more times, and after four months, the tumour stopped growing. Ten more doses of the modified immune cells were added to stop a number of other smaller growths in the patient’s brain. Importantly, the low dosages of CAR-T cells did not cause any serious complications or damage the patient’s brain any further. After 7.5 months, almost all tumours had disappeared.
“I believe these recent results show we have a potential breakthrough treatment that may have a remarkable impact on patients with malignant brain tumours,” noted Badie in a release.
Encouragingly, there are nine other patients enrolled in this study, and they’re all responding similarly. And because the modified cells were injected directly to the tumour site, and not intravenously as has been done in other CAR-T treatments, this technique could be used to target other solid tumor cancers, such as pediatric brain cancers and even breast and prostate cancers.
Here’s the bad news: tumours have re-emerged in the patient’s brain, though in areas not treated with the CAR-T cells. Badie says these tumours are comprised of receptor proteins that aren’t recognised by the modified immune cells, implying that future treatments will likely have to include an array of CAR-T cells, each designed to target a specific brand of tumor. That presents an immediate and obvious challenge to the researchers.

Tags: braincancerhealthmedicineresearch

Read original article » Back to category


Author: Guest
Posted: 2017-01-04
CAR-T cells are showing great promise for cancer therapy and not only for lymphoma and leukaemia, this research shows that solid tumours such as difficult brain tumour are also responding-great!
1 Replies
Author: Guest
Posted: 2017-01-04
I agree, we know need to see big clinical trials for CAR-T cells for different cancer types to move on from promising case studies Reply


Recent headlines

  • Posted in Software on 2018-05-26 01:48:47
    From Here to Human-Level AGI in Four Simple more
    Posted in Science on 2018-05-26 01:41:34
    Research Team Builds a Brain Model Neuron By more
    Posted in Hardware on 2018-05-24 04:45:19
    30% Efficiency Solar more
    Posted in Software on 2018-05-24 04:41:49
    Samsung plans AI research centers in Canada, UK more
    Posted in Science on 2018-05-24 04:38:06
    Every 3-5 years SpaceX is adding a decade lead more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs, more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target more

Recent Blog Posts

  • Posted by AlexMuller
    In five years quantum computing will be more
    Posted by AlexMuller
    Google partners with Johnson and Johnson to make lower more
    Posted by AlexMuller
    Electron holography microscope with spatial resolution down more
    Posted by AlexMuller
    Lower cost advanced Nuclear power could dominate future US more
    Posted by AlexMuller
    Why Hasn’t AI Mastered Language Translation? more

Login to your Account

Login to your PlanetTech Account here

Remember me

Create a New Account

You just need username and password

The following errors occured:
Verify password:
Remember me